In the same study, increased TILs score was also associated with longer overall survival in TNBC, but no association was found in HER2-positive breast cancer.[12] In all of these studies, patients received only chemotherapy in neoadjuvant therapy. This evidence concerns the gene ERBB2 and breast cancer.